Conivaptan: all 21 studies that test it

Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.

• Conivaptan for the Reduction of Cerebral Edema in Intracerebral Hemorrhage- A Safety and Tolerability StudyCompletedNCT03000283Phase 1Results posted
• A Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous Conivaptan (Vaprisol®) in Pediatric Subjects With Euvolemic or Hypervolemic HyponatremiaTerminatedNCT01451411Phase 3Results posted
• Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)TerminatedNCT00843986Phase 3Results posted
• Use of Conivaptan (Vaprisol) for Hyponatremic Neuro-ICU PatientsTerminatedNCT00727090Phase 4Results posted
• A Study to Assess the Safety and Effects of Intravenous (IV) Conivaptan on the Hepatic Hemodynamic Response in Cirrhotic PatientsCompletedNCT00592475Phase 2Results posted
• Study of Efficacy & Safety for 3 Infusion Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00478192Phase 3Results posted
• A Study of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00435591Phase 4Results posted
• Study of Stroke Related Edema TreatmentsWithdrawnNCT01954290Phase 2
• Effects on Exercise Hemodynamics of Vasopressin Blockade by Conivaptan Infusion in Heart Failure PatientsCompletedNCT01752543Phase 4
• A Study to Assess the Effect of Severe Hepatic Impairment on the Pharmacokinetics of Intravenous ConivaptanCompletedNCT01370148Phase 1
• Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain InjuryCompletedNCT00930202Phase 1
• Comparing the Effects of Conivaptan and Diuretics on Plasma Neurohormones and Renal Blood Flow in Patients With Chronic Congestive Heart FailureStatus unknownNCT00924014Not applicable
• Study to Compare Conivaptan Pharmacokinetics in Subjects With Mild & Moderate Kidney Function Impairment to Subjects With Normal Kidney FunctionCompletedNCT00887627Phase 1
• Study to Compare Conivaptan in Subjects With Mild & Moderate Liver Impairment Versus Subjects With Normal Liver FunctionCompletedNCT00851227Phase 1
• Body Volume Regulation in Pulmonary Arterial Hypertension With Right Ventricular FailureWithdrawnNCT00811486Not applicable
• Diuretic and Renal Effects of Vaprisol When Administered Along With Furosemide and Nesiritide Continuous InfusionWithdrawnNCT00806910Phase 4
• Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological PatientsWithdrawnNCT00684164Phase 3
• Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00492037Phase 3
• Study of IV YM087 to Assess Efficacy and Safety in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00380575Phase 3
• An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic HyponatremiaCompletedNCT00379847Phase 3
• Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart FailureCompletedNCT00057356Phase 2

← Conivaptan overview